The metabolic syndrome - a group of factors that raise the risk of cardiovascular disease and type 2 diabetes - is increasingly common. How might the challenges of developing improved therapies to normalize these risk factors be approached?
CITATION STYLE
Grundy, S. M. (2009). Advancing drug therapy of the metabolic syndrome. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd2894
Mendeley helps you to discover research relevant for your work.